DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Biosensors that measure glucose are now available without a prescription. Wearing one nearly burst my wellness bubble.

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively ...

Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...

Ultimately, the right stocks for your portfolio will depend on numerous factors, including your risk tolerance level, ...

We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

DexCom has helped revolutionize diabetes care with continuous glucose monitoring (CGM) devices. Patients wear a patch that continuously transmits blood sugar data to a device or smartphone.

Lithuania has proven to be an excellent fit for Dexcom due to its strong business environment, skilled workforce, and ...

Sanctuary Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the second ...